<table id="table6" width="80%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 6:	 Effect of VYVANSE on Other Drugs</caption>
<col align="left" valign="top" width="25%"></col>
<col align="left" valign="top" width="50%"></col>
<col align="left" valign="top" width="25%"></col>
<thead>
<tr>
<th stylecode="Lrule Rrule">Concomitant Drug Name or Drug Class</th>
<th stylecode="Rrule">Clinical Rationale</th>
<th stylecode="Rrule">Clinical Recommendation</th>
</tr>
</thead>
<tbody>
<tr>
<td stylecode="Lrule Rrule">Monoamine Oxidase Inhibitors (MAOIs)</td>
<td stylecode="Rrule">Concomitant use of MAOIs and CNS stimulants can cause hypertensive crisis.  Potential outcomes include death, stroke, myocardial infarction, aortic dissection, ophthalmological complications, eclampsia, pulmonary edema, and renal failure.</td>
<td stylecode="Rrule">Do not administer VYVANSE concomitantly or within 14 days after discontinuing MAOI treatment <content stylecode="italics"> [see <linkhtml href="#S4">Contraindications (4)</linkhtml>]</content>
</td>
</tr>
</tbody>
</table>